 What happened Shares in MEI Pharma NASDAQ: MEIP are tumbling 15.3 at 11:55 a.m. EDT on Thursday following news its collaboration partner, Helsinn Group, is discontinuing a phase 3 trial of pracinostat in acute myeloid leukemia, or AML. 